NOC
47
2
MA
60
3
CCL
53
6
TMO
47
4
STI
20
2
HES
67
4
KMB
48
-2
OI
43
4
THC
56
2
WU
36
-14
UNM
71
5
XEL
69
7
JNJ
56
-3
GOOGL
45
2
PNW
73
2
CMG
50
7
DTE
63
4
IBM
57
2
TXN
35
3
EOG
39
3
NOC
47
2
MA
60
3
CCL
53
6
TMO
47
4
STI
20
2
HES
67
4
KMB
48
-2
OI
43
4
THC
56
2
WU
36
-14
UNM
71
5
XEL
69
7
JNJ
56
-3
GOOGL
45
2
PNW
73
2
CMG
50
7
DTE
63
4
IBM
57
2
TXN
35
3
EOG
39
3
Financhill
Back

NeuroOne Medical Technologies 10K Form

Sell
43

NMTC
NeuroOne Medical Technologies

Last Price:
$1.07
Seasonality Move:
-32.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-12 10K NMTC/NeuroOne Medical Technologies Annual
2021-01-28 10K NMTC/NeuroOne Medical Technologies Annual
2020-12-09 10K NMTC/NeuroOne Medical Technologies Annual
2020-08-13 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-05-14 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-02-14 10Q NMTC/NeuroOne Medical Technologies Quarterly

Receive NMTC News And Ratings

See the #1 stock for the next 7 days that we like better than NMTC

NMTC Financial Statistics

Sales & Book Value

Annual Sales: $3.5M
Cash Flow: $183.6K
Price / Cash Flow: 0
Annual Sales: $0.10
Price / Book: 11.36

Profitability

EPS (TTM): -0.26000
Net Income (TTM): $-7.2M
Gross Margin: $1.1M
Return on Equity: -238.93%
Return on Assets: -128.38%

NeuroOne Medical Technologies Earnings Forecast

Key NeuroOne Medical Technologies Financial Ratios

  • The Gross Profit Margin over the past 15 years for NMTC is 31.27%.
  • The Selling, General & Administrative Expenses for NMTC have been equal to 228.84% of Gross Profit Margin.
  • The Research & Development expenses have been 146.69% of Revenue.
  • The Net Earning history of NMTC is -356.74% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 6 years.

NeuroOne Medical Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: NMTC
Website: n1mtc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.64
Quick Ratio: 2.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NMTC Technical Analysis vs Fundamental Analysis

Sell
43
NeuroOne Medical Technologies (NMTC) is a Sell

Is NeuroOne Medical Technologies a Buy or a Sell?